{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:51:03Z","timestamp":1782514263443,"version":"3.54.5"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":523,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1002\/rth2.12570","type":"journal-article","created":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T21:04:45Z","timestamp":1627851885000},"page":"e12570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Menstruation, anticoagulation, and contraception: VTE and uterine bleeding"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9981-8990","authenticated-orcid":false,"given":"Bethany","family":"Samuelson Bannow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4771-8760","authenticated-orcid":false,"given":"Claire","family":"McLintock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/rth2.12570_bb0010","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/j.1471-0528.1985.tb03031.x","article-title":"Coagulation factors and fibrinolytic proteins in menstrual fluid collected from normal and menorrhagic women","volume":"92","author":"Rees","year":"1985","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1002\/rth2.12570_bb0015","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/00016348109154110","article-title":"Fibrinolytic activity of human uterine fluid","volume":"60","author":"Casslen","year":"1981","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1002\/rth2.12570_bb0020","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.thromres.2009.06.013","article-title":"Tissue factor and the endometrium: from physiology to pathology","volume":"124","author":"Krikun","year":"2009","journal-title":"Thromb Res"},{"key":"10.1002\/rth2.12570_bb0025","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/oxfordjournals.humrep.a136694","article-title":"Observation of the activity of factor VIII in the endometrium of women with regular menstrual cycles","volume":"3","author":"Zhu","year":"1988","journal-title":"Hum Reprod"},{"key":"10.1002\/rth2.12570_bb0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijgo.2010.11.011","article-title":"FIGO classification system (PALM\u2010COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age","volume":"113","author":"Munro","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1002\/rth2.12570_bb0035","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.vph.2016.11.003","article-title":"Heavy menstrual bleeding in women treated with rivaroxaban and vitamin K antagonists and the risk of recurrent venous thromboembolism","volume":"87","author":"Bryk","year":"2016","journal-title":"Vascul Pharmacol"},{"key":"10.1002\/rth2.12570_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2017.05.001","article-title":"Abnormal uterine bleeding in women receiving direct oral anticoagulants for the treatment of venous thromboembolism","volume":"93\u201395","author":"Godin","year":"2017","journal-title":"Vascul Pharmacol"},{"key":"10.1002\/rth2.12570_bb0045","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1111\/jth.14226","article-title":"Less abnormal uterine bleeding with dabigatran than warfarin in women treated for acute venous thromboembolism","volume":"16","author":"Huisman","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1002\/rth2.12570_bb0050","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.thromres.2020.11.014","article-title":"Heavy menstrual bleeding in women on oral anticoagulants","volume":"197","author":"Samuelson Bannow","year":"2021","journal-title":"Thromb Res"},{"key":"10.1002\/rth2.12570_bb0055","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood-2015-08-665927","article-title":"Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use","volume":"127","author":"Martinelli","year":"2016","journal-title":"Blood"},{"key":"10.1002\/rth2.12570_bb0060","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2147\/IJWH.S65481","article-title":"Noncontraceptive benefits of the estradiol valerate\/dienogest combined oral contraceptive: a review of the literature","volume":"6","author":"Nappi","year":"2014","journal-title":"Int J Womens Health"},{"issue":"3","key":"10.1002\/rth2.12570_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6503a1","article-title":"U.S. Medical eligibility criteria for contraceptive use, 2016","volume":"65","author":"Curtis","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"10.1002\/rth2.12570_bb0070","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/01443615.2015.1024210","article-title":"Comparison of combined hormonal vaginal ring with ultralow\u2010dose combined oral contraceptive pills in the management of heavy menstrual bleeding: a pilot study","volume":"36","author":"Agarwal","year":"2016","journal-title":"J Obstet Gynaecol"},{"key":"10.1002\/rth2.12570_bb0075","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1471-0528.1990.tb16240.x","article-title":"Levonorgestrel\u2010releasing intrauterine device in the treatment of menorrhagia","volume":"97","author":"Andersson","year":"1990","journal-title":"BJOG: Int J Obstetr Gynaecol"},{"issue":"Suppl 1","key":"10.1002\/rth2.12570_bb0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/13625180801959931","article-title":"The effects of Implanon on menstrual bleeding patterns","volume":"13","author":"Mansour","year":"2008","journal-title":"Eur J Contracept Reprod Health Care"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12570","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/rth2.12570","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922014297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922014297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12570","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:22:18Z","timestamp":1762863738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037922014297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S2475037922014297"],"URL":"https:\/\/doi.org\/10.1002\/rth2.12570","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.740630575.793588983","asserted-by":"object"}]},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Menstruation, anticoagulation, and contraception: VTE and uterine bleeding","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1002\/rth2.12570","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 The Authors. Research and Practice in Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis","name":"copyright","label":"Copyright"}],"article-number":"e12570"}}